| 11.2 -0.49 (-4.19%) | 03-05 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 15.82  |
1-year : | 17.57 |
| Resists | First : | 13.54 |
Second : | 15.04 |
| Pivot price | 13.69 |
|||
| Supports | First : | 11.13 |
Second : | 9.26 |
| MAs | MA(5) : | 11.96 |
MA(20) : | 13.88 |
| MA(100) : | 15.25 |
MA(250) : | 21.13 |
|
| MACD | MACD : | -0.7 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 4.8  |
D(3) : | 6.4 |
| RSI | RSI(14): 24 |
|||
| 52-week | High : | 28.41 | Low : | 11.13 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PRGO ] has closed above bottom band by 2.2%. Bollinger Bands are 74% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 11.69 - 11.75 | 11.75 - 11.81 |
| Low: | 10.93 - 11.02 | 11.02 - 11.1 |
| Close: | 11.07 - 11.2 | 11.2 - 11.31 |
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Tue, 03 Mar 2026
Perrigo Company plc (PRGO) Stock Analysis: High Dividend Yield Offers Tempting 37.76% Potential Upside - DirectorsTalk Interviews
Tue, 03 Mar 2026
Perrigo to Present at the UBS Global Consumer and Retail Conference - Finviz
Tue, 03 Mar 2026
Hear Perrigo CEO's UBS consumer conference talk via live webcast - Stock Titan
Mon, 02 Mar 2026
Perrigo Company plc (NYSE:PRGO) Receives Average Rating of "Hold" from Analysts - MarketBeat
Mon, 02 Mar 2026
Bahl & Gaynor Inc. Has $46.48 Million Stake in Perrigo Company plc $PRGO - MarketBeat
Sat, 28 Feb 2026
PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View - The Globe and Mail
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 138 (M) |
| Shares Float | 137 (M) |
| Held by Insiders | 0.4 (%) |
| Held by Institutions | 115.1 (%) |
| Shares Short | 15,850 (K) |
| Shares Short P.Month | 15,380 (K) |
| EPS | -0.21 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 32.31 |
| Profit Margin | -1.3 % |
| Operating Margin | 8.9 % |
| Return on Assets (ttm) | 2.7 % |
| Return on Equity (ttm) | -0.7 % |
| Qtrly Rev. Growth | -4.1 % |
| Gross Profit (p.s.) | 11.04 |
| Sales Per Share | 31.1 |
| EBITDA (p.s.) | 5.78 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 376 (M) |
| Levered Free Cash Flow | 358 (M) |
| PE Ratio | -53.34 |
| PEG Ratio | 0 |
| Price to Book value | 0.34 |
| Price to Sales | 0.36 |
| Price to Cash Flow | 4.1 |
| Dividend | 0.28 |
| Forward Dividend | 0 |
| Dividend Yield | 2.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|